Literature DB >> 21748283

Behavioral, structural and molecular changes following long-term hippocampal IL-1β overexpression in transgenic mice.

Amy M Hein1, Troy J Zarcone, David B Parfitt, Sarah B Matousek, Dena M Carbonari, John A Olschowka, M Kerry O'Banion.   

Abstract

Chronic neuroinflammation is associated with many neurodegenerative and neurocognitive disorders, yet few animal models exist to study the behavioral effects of prolonged neuroinflammation. Therefore, we recently developed a transgenic mouse model harboring an interleukin-1β excisional activation transgene (IL-1β(XAT)). These mice display localized IL-1β overexpression and resultant neuroinflammation for up to 1 year following transgene induction. Initial behavioral studies demonstrated long-term memory deficits after 2 weeks of hippocampal IL-1β overexpression. In the present studies, we extend these behavioral studies both in scope and timing. We find long-term contextual but not auditory fear memory impairments following 3 months of IL-1β overexpression. On a battery of other behavioral tests, IL-1β overexpression in IL-1β(XAT) mice increased locomotor activity, especially in female mice, and had slight anxiolytic effects. No differences were found in operant conditioning or in basal or stress-induced CORT levels, despite profound hippocampal glial activation. Interestingly, the volume of discrete hippocampal cell layers was reduced after 6 but not 3 months of IL-1β overexpression. Therefore, this animal model provides a novel tool for examining the effects of chronic inflammation on discrete brain regions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21748283      PMCID: PMC3214690          DOI: 10.1007/s11481-011-9294-3

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  40 in total

1.  Behavioral and ultrastructural changes induced by chronic neuroinflammation in young rats.

Authors:  B Hauss-Wegrzyniak; M G Vannucchi; G L Wenk
Journal:  Brain Res       Date:  2000-03-17       Impact factor: 3.252

2.  The comparison of changes in behavior, neurochemistry, endocrine, and immune functions after different routes, doses and durations of administrations of IL-1beta in rats.

Authors:  C Song; D F Horrobin; B E Leonard
Journal:  Pharmacopsychiatry       Date:  2006-05       Impact factor: 5.788

3.  Intraarticular induction of interleukin-1beta expression in the adult mouse, with resultant temporomandibular joint pathologic changes, dysfunction, and pain.

Authors:  Yu-Ching Lai; Solomon S Shaftel; Jen-nie H Miller; Ross H Tallents; Yoon Chang; Carl A Pinkert; John A Olschowka; Ian M Dickerson; J Edward Puzas; M Kerry O'Banion; Stephanos Kyrkanides
Journal:  Arthritis Rheum       Date:  2006-04

4.  Acute diclofenac treatment attenuates lipopolysaccharide-induced alterations to basic reward behavior and HPA axis activation in rats.

Authors:  Richard De La Garza; Gregory M Asnis; Kevin R Fabrizio; Erika Pedrosa
Journal:  Psychopharmacology (Berl)       Date:  2004-11-25       Impact factor: 4.530

5.  Chronic interleukin-1beta expression in mouse brain leads to leukocyte infiltration and neutrophil-independent blood brain barrier permeability without overt neurodegeneration.

Authors:  Solomon S Shaftel; Thaddeus J Carlson; John A Olschowka; Stephanos Kyrkanides; Sarah B Matousek; M Kerry O'Banion
Journal:  J Neurosci       Date:  2007-08-29       Impact factor: 6.167

6.  Inflammation in human brain injury: intracerebral concentrations of IL-1alpha, IL-1beta, and their endogenous inhibitor IL-1ra.

Authors:  Peter J Hutchinson; Mark T O'Connell; Nancy J Rothwell; Stephen J Hopkins; Jürgens Nortje; Keri L H Carpenter; Ivan Timofeev; Pippa G Al-Rawi; David K Menon; John D Pickard
Journal:  J Neurotrauma       Date:  2007-10       Impact factor: 5.269

7.  Effects of interleukin-1beta and lipopolysaccharide on behavior of mice in the elevated plus-maze and open field tests.

Authors:  Artur H Swiergiel; Adrian J Dunn
Journal:  Pharmacol Biochem Behav       Date:  2007-02-16       Impact factor: 3.533

8.  Memory for context is impaired by a post context exposure injection of interleukin-1 beta into dorsal hippocampus.

Authors:  Ruth M Barrientos; Emily A Higgins; David B Sprunger; Linda R Watkins; Jerry W Rudy; Steven F Maier
Journal:  Behav Brain Res       Date:  2002-08-21       Impact factor: 3.332

9.  Sustained hippocampal IL-1 beta overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology.

Authors:  Solomon S Shaftel; Stephanos Kyrkanides; John A Olschowka; Jen-nie H Miller; Renee E Johnson; M Kerry O'Banion
Journal:  J Clin Invest       Date:  2007-06       Impact factor: 14.808

Review 10.  Interleukin-1 and neuronal injury.

Authors:  Stuart M Allan; Pippa J Tyrrell; Nancy J Rothwell
Journal:  Nat Rev Immunol       Date:  2005-08       Impact factor: 53.106

View more
  12 in total

1.  Neuroinflammation and cognitive dysfunction in chronic disease and aging.

Authors:  Amy M Hein; M Kerry O'Banion
Journal:  J Neuroimmune Pharmacol       Date:  2012-01-18       Impact factor: 4.147

2.  IL-1 receptor antagonist attenuates neonatal lipopolysaccharide-induced long-lasting learning impairment and hippocampal injury in adult rats.

Authors:  Kuo-Mao Lan; Lu-Tai Tien; Yi Pang; Abhay J Bhatt; Lir-Wan Fan
Journal:  Toxicol Lett       Date:  2015-02-07       Impact factor: 4.372

3.  Neonatal lipopolysaccharide exposure induces long-lasting learning impairment, less anxiety-like response and hippocampal injury in adult rats.

Authors:  K-C Wang; L-W Fan; A Kaizaki; Y Pang; Z Cai; L-T Tien
Journal:  Neuroscience       Date:  2013-01-05       Impact factor: 3.590

4.  Adult murine hippocampal neurogenesis is inhibited by sustained IL-1β and not rescued by voluntary running.

Authors:  Michael D Wu; Amy M Hein; Michael J Moravan; Solomon S Shaftel; John A Olschowka; M Kerry O'Banion
Journal:  Brain Behav Immun       Date:  2011-09-29       Impact factor: 7.217

Review 5.  Visceral adiposity, inflammation, and hippocampal function in obesity.

Authors:  Alexis M Stranahan
Journal:  Neuropharmacology       Date:  2021-12-10       Impact factor: 5.273

6.  Sustained IL-1β expression impairs adult hippocampal neurogenesis independent of IL-1 signaling in nestin+ neural precursor cells.

Authors:  Michael D Wu; Sara L Montgomery; Fatima Rivera-Escalera; John A Olschowka; M Kerry O'Banion
Journal:  Brain Behav Immun       Date:  2013-03-16       Impact factor: 7.217

7.  BDNF-TrkB signaling through Erk1/2 MAPK phosphorylation mediates the enhancement of fear memory induced by glucocorticoids.

Authors:  J-M Revest; A Le Roux; V Roullot-Lacarrière; N Kaouane; M Vallée; F Kasanetz; F Rougé-Pont; F Tronche; A Desmedt; P V Piazza
Journal:  Mol Psychiatry       Date:  2013-10-15       Impact factor: 15.992

8.  Galactic cosmic radiation leads to cognitive impairment and increased aβ plaque accumulation in a mouse model of Alzheimer's disease.

Authors:  Jonathan D Cherry; Bin Liu; Jeffrey L Frost; Cynthia A Lemere; Jacqueline P Williams; John A Olschowka; M Kerry O'Banion
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

Review 9.  Rodent models of depression: neurotrophic and neuroinflammatory biomarkers.

Authors:  Mikhail Stepanichev; Nikolay N Dygalo; Grigory Grigoryan; Galina T Shishkina; Natalia Gulyaeva
Journal:  Biomed Res Int       Date:  2014-06-05       Impact factor: 3.411

10.  Effect of the IL-1 Receptor Antagonist Kineret® on Disease Phenotype in mdx Mice.

Authors:  Margaret E Benny Klimek; Arpana Sali; Sree Rayavarapu; Jack H Van der Meulen; Kanneboyina Nagaraju
Journal:  PLoS One       Date:  2016-05-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.